Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Streets Top analysts upgrades, downgrades and initiations for Wednesday, as follows:

Allergan PLC (NYSE:AGN) was reiterated as Buy with a 280 price target at Argus.

Calyxt Inc. (NASDAQ:CLXT) was started as Buy and assigned a 16 price target at Jefferies, and Wells Fargo started coverage as Outperform with a 17 price target.

Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) was reiterated as Outperform and with a 34 price target at Wedbush Securities.

FirstEnergy Corp. (NYSE:FE) was raised to Outperform from In-Line at Evercore ISI.

Kala Pharmaceuticals Inc.  (NASDAQ:KALA) was started as Outperform with a 46 price target at Wedbush. JPMorgan started coverage as Overweight and assigned a 35 price target. Merrill Lynch started it with a Buy rating and a $33 price objective.

Stay tuned…


The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.